A detailed history of Sea Crest Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 5,991 shares of MRNA stock, worth $244,193. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,991
Previous 6,624 9.56%
Holding current value
$244,193
Previous $786,000 49.11%
% of portfolio
0.04%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$63.64 - $125.14 $40,284 - $79,213
-633 Reduced 9.56%
5,991 $400,000
Q2 2024

Jul 19, 2024

BUY
$101.21 - $166.61 $708 - $1,166
7 Added 0.11%
6,624 $786,000
Q1 2024

Apr 18, 2024

SELL
$85.37 - $115.44 $30,050 - $40,634
-352 Reduced 5.05%
6,617 $705,000
Q4 2023

Jan 18, 2024

BUY
$69.51 - $104.43 $138,533 - $208,128
1,993 Added 40.05%
6,969 $693,000
Q3 2023

Oct 12, 2023

SELL
$96.41 - $126.61 $25,837 - $33,931
-268 Reduced 5.11%
4,976 $513,000
Q2 2023

Jul 14, 2023

SELL
$118.5 - $160.53 $156,420 - $211,899
-1,320 Reduced 20.11%
5,244 $637,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $18,314 - $26,597
-135 Reduced 2.02%
6,564 $1.01 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $29,239 - $51,879
-247 Reduced 3.56%
6,699 $1.2 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $329,061 - $541,179
-2,787 Reduced 28.63%
6,946 $821,000
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $50,951 - $76,816
435 Added 4.68%
9,733 $1.39 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $82,451 - $153,252
-652 Reduced 6.55%
9,298 $1.6 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $253,595 - $413,836
1,123 Added 12.72%
9,950 $2.53 Million
Q3 2021

Nov 16, 2021

BUY
$221.9 - $484.47 $249,193 - $544,059
1,123 Added 14.58%
8,827 $3.4 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $127,051 - $229,810
978 Added 14.54%
7,704 $1.81 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $56,664 - $96,523
-519 Reduced 7.16%
6,726 $881,000
Q4 2020

Feb 09, 2021

SELL
$65.74 - $169.86 $172,041 - $444,523
-2,617 Reduced 26.54%
7,245 $757,000
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $206,165 - $359,860
-3,794 Reduced 27.78%
9,862 $698,000
Q2 2020

Jul 27, 2020

BUY
$29.67 - $80.0 $405,173 - $1.09 Million
13,656 New
13,656 $877,000
Q2 2019

Jul 19, 2019

SELL
$13.7 - $28.34 $2,740 - $5,668
-200 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$14.45 - $23.7 $1,445 - $2,370
-100 Reduced 33.33%
200 $4,000
Q4 2018

Feb 13, 2019

BUY
$13.52 - $18.8 $4,056 - $5,640
300 New
300 $5,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.